Al Kildani | Vice President of Investor Relations & Corporate Communications |
Helen Torley | President & Chief Executive Officer |
Elaine Sun | Chief Financial Officer |
Charles Duncan | Cantor Fitzgerald |
Do Kim | BMO |
Jim Birchenough | Wells Fargo |
Anita Dushyanth | Berenberg Capital |
Benjamin Paluch | Citi |
Ben Shim | Canaccord Genuity |
Ladies and gentlemen, thank you for standing by and welcome to the Halozyme Fourth Quarter 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr.